Abstract:BackgroundFactitious hypoglycemia, a deliberate attempt to induce low blood glucose levels occurring secondary to the surreptitious administration of exogenous insulin, can be difficult to diagnose due to a variety of factors including the increased use of synthetic insulin analogs in clinical practice. Traditional insulin immunoassays demonstrate variable cross-reactivity with commonly prescribed insulin analogues and their metabolites, making it difficult to measure specific analogs. The development of liquid chromatography high resolution accurate mass (LC-HRAM)-mass spectrometry (MS) assays has largely circumvented the limitations of traditional immunoassays for detection and quantitation of insulin analogs. Analytical challenges remain, however, specifically in differentiating lispro, an isomeric human insulin analog formed by the transposition of proline and lysine near the C-terminal end of the B chain, from human insulin in patient samples due to the equivalent mass-to-charge ratios of their precursor ions.MethodsImmunoaffinity purification of insulin from calibrators and quality control material prepared by spiking insulin-depleted serum with pharmaceutical insulin preparations, as well as patient samples, was performed using tips coupled with anti-insulin monoclonal antibody. An automated liquid handler was programmed to perform aspiration and dispense cycles. Eluate from the purification protocol was submitted for analysis using a TLX-2 multiplex LC system paired with a Thermo Scientific Q Exactive Plus mass spectrometer. Various HPLC column chemistries were evaluated, a column passivation procedure was established, and column heater temperature was optimized to identify a combination of parameters yielding the best chromatographic separation of human insulin and lispro. Additionally, parallel reaction monitoring (PRM) targeted tandem mass spectrometry (MS/MS) analysis was utilized in combination with the full scan data to increase specificity through the monitoring of fragment ions produced from human insulin and each insulin analog.ResultsWe found that a 1000 Å Diphenyl, 2.7 μm, 2.1 x 100 mm analytical column in a column heater maintained at a temperature of 80°C allowed for human insulin and lispro to be differentiated as two chromatographically separated extracted ion chromatographic peaks (XICs) and quantified down to 2.5 mcIU/mL with near-baseline separation. Before use, the column required passivation with a high protein buffer (0.05% bovine serum albumin in 20% acetonitrile [ACN] + 0.2% acetic acid) followed by increasingly organic buffers (20% ACN + 0.2% acetic acid and 50% ACN + 0.2% acetic acid). MS/MS was used to confirm the presence of analogs detected.ConclusionsThe LC-HRAM-MS method described here, coupled with optimized column chemistry, column passivation, and proper column temperature control allows for chromatographic separation of human insulin and lispro. Incorporating a PRM scan into the mass spectrometry full scan method provides confirmation of the insulin detected in the XICs. The results obtained from preliminary studies suggest this method is appropriate for use to facilitate the clinical investigation of suspected factitious hypoglycemia with the ability to differentiate isomeric compounds, such as human insulin and lispro.

Identification of sulfonylureas in serum by electrospray mass spectrometry

Detection of recombinant insulins in human urine by liquid chromatography–electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns

BIOANALYTICAL METHOD BY COLUMN-SWITCHING WITH DIRECT INJECTION OF HUMAN PLASMA FOR DETERMINATION OF SULPHONYLUREAS

Determination of sulpiride by capillary electrophoresis with end-column electrogenerated chemiluminescence detection

Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma

Simultaneous Identification, Confirmation and Quantitation of Illegal Adulterated Antidiabetics in Herbal Medicines and Dietary Supplements Using High-Resolution Benchtop Quadrupole-Orbitrap Mass Spectrometry.

B-150 Chromatographic Separation and Quantitation of Human Insulin and Lispro Analog in Serum Using Liquid Chromatography High-Resolution Mass Spectrometry

Rapid, Simple, Specific Liquid Chromatographic-Electrospray Mass Spectrometry Method for the Determination of Glibenclamide in Human Plasma

Chemometrics-enhanced Full Scan Mode of Liquid Chromatography–mass Spectrometry for the Simultaneous Determination of Six Co-Eluted Sulfonylurea-Type Oral Antidiabetic Agents in Complex Samples

LC–MS Determination and Pharmacokinetic Study of a Novel Sulfonylurea: Potential Hypoglycemic Agent in Rat Plasma

Complementary Strategy Enhancing Broad-Specificity for Multiplexed Immunoassay of Adulterant Sulfonylureas in Functional Food

Quantification of Insulin Analogs by Liquid Chromatography-High-Resolution Mass Spectrometry

Hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry combined with fabric phase sorptive extraction for therapeutic drug monitoring of pioglitazone, repaglinide, and nateglinide in human plasma

Utilizing ELISA-plate based immunopurification and liquid chromatography-tandem mass spectrometry for the urinary detection of short- and long acting human insulin analogues

Simultaneous determination of amino acids, purines and derivatives in serum by UHPLC/MS/MS.

Quantitative Determination of Metformin, Saxagliptin and 5-Hydroxy Saxagliptin Simultaneously by Hydrophilic Interaction Liquid Chromatography - Electrospray Ionization Mass Spectrometry and Its Application to a Bioequivalence Study with a Single-Pill Combination in Human

Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry

C18-attached Membrane Funnel-Based Spray Ionization Mass Spectrometry for Quantification of Anti-Diabetic Drug from Human Plasma.

Simultaneous Determination of Illegal Additives in Dietary Supplements and Traditional Medicines by High Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry [erratum: 2009 May 15, V. 114, No. 2, P. 763.]

Simultaneous analysis of antihyperglycemic small molecule drugs and peptide drugs by means of dual liquid chromatography high-resolution mass spectrometry

Simultaneous Determination of Metformin and Rosiglitazone in Human Plasma by Liquid Chromatography/tandem Mass Spectrometry with Electrospray Ionization: Application to a Pharmacokinetic Study.